Decreased Circulating Soluble Tie2 Levels in Preeclampsia May Result from Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling
Author(s) -
Joyce F. Sung,
Xiujun Fan,
Sabita Dhal,
Bonnie K. Dwyer,
Anahita Jafari,
Yasser Y. ElSayed,
Maurice L. Druzin,
Nihar R. Nayak
Publication year - 2011
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-0063
Subject(s) - angiopoietin receptor , preeclampsia , vascular endothelial growth factor , angiopoietin , endocrinology , medicine , placenta , vascular endothelial growth factor a , kinase insert domain receptor , matrix metalloproteinase , placental growth factor , basal (medicine) , angiogenesis , pregnancy , fetus , biology , vegf receptors , insulin , genetics
Recent studies have found dysregulation in circulating levels of a number of angiogenic factors and their soluble receptors in preeclampsia. In this study, we examined the mechanism of production of soluble Tie2 (sTie2) and its potential connection to the failure of vascular remodeling in preeclamptic pregnancies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom